Candel Therapeutics (CADL) Capital Expenditures (2020 - 2025)
Candel Therapeutics (CADL) posted Capital Expenditures of -$46000.0 for Q4 2025, down 131.94% sequentially from $144000.0 in Q3 2025, and down 1633.33% YoY from $3000.0 in Q4 2024.
Candel Therapeutics (CADL) Capital Expenditures (2020 - 2025) Analysis & Trends
Candel Therapeutics has reported Capital Expenditures for 6 years, with the latest figure at -$46000.0 in Q4 2025.
- Quarterly Capital Expenditures fell 1633.33% year-over-year to -$46000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $132000.0 (up 725.0% YoY) and the FY2025 annual result came in at $132000.0, up 725.0% from the prior year.
- Capital Expenditures fell to -$46000.0 in Q4 2025 per CADL's latest filing, from $144000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $1.8 million in Q1 2021 and troughed at -$1.4 million in Q4 2021.
- A 5-year average of $31105.3 and a median of $6000.0 in 2024 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2021 and 2022: Capital Expenditures tumbled 10200.0% in 2021, then surged 372.95% in 2022.
- Over 5 years, Capital Expenditures stood at -$1.4 million in 2021, then jumped by 32.67% to -$952000.0 in 2022, then soared by 146.01% to $438000.0 in 2023, then tumbled by 99.32% to $3000.0 in 2024, then tumbled by 1633.33% to -$46000.0 in 2025.
- According to Business Quant data, Capital Expenditures over the past three periods registered -$46000.0, $144000.0, and $18000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.29 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 572,662.23 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 251.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 34.68 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Candel Therapeutics | 643.41 Mn | 643.41 Mn | - | -46,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -46,000.00 |
| Dec 31, 2025 | -46,000.00 |
| Sep 30, 2025 | 144,000.00 |
| Sep 30, 2025 | 144,000.00 |
| Jun 30, 2025 | 18,000.00 |
| Jun 30, 2025 | 18,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Dec 31, 2023 | 438,000.00 |
| Dec 31, 2023 | 438,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Jun 30, 2023 | -122,000.00 |
| Jun 30, 2023 | -122,000.00 |